Mostafa M. Elbadawi, Wagdy M. Eldehna, Amer Ali Abd El-Hafeez, Warda R. Somaa, Amgad Albohy, Sara T. Al-Rashood, . . . Manabu Abe. (2022). 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: Synthesis, biological evaluation, and molecular modelling insights. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMostafa M. Elbadawi, et al. 2-Arylquinolines as Novel Anticancer Agents with Dual EGFR/FAK Kinase Inhibitory Activity: Synthesis, Biological Evaluation, and Molecular Modelling Insights. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationMostafa M. Elbadawi, et al. 2-Arylquinolines as Novel Anticancer Agents with Dual EGFR/FAK Kinase Inhibitory Activity: Synthesis, Biological Evaluation, and Molecular Modelling Insights. Taylor & Francis Group, 2022.